Shiseido withdrew a jamu patent after NGO pressure; kratom patents were contested
Short record: the main facts, with sources. A full case file has not been prepared.
- The record does not name which of my species, waters, soils or forests were harmed.
Shiseido withdrew a patent on compounds from jamu, an Indonesian herbal medicine, after pressure from an Indonesian NGO. Patents on Thailand's kratom plant, held by Japanese universities, were challenged by BioThai.
- Shiseido — held a patent on 11 active compounds from jamu until its withdrawal Preprints.org
- Chiba and Josai universities — held kratom patents that BioThai challenged Bangkok Post
What happened
A 2025 preprint on Indonesian biopiracy reports that Shiseido withdrew its patent on 11 active compounds from jamu after pressure from an Indonesian NGO.
BioThai objected to kratom patents held by Chiba and Josai universities, and four patents were still registered in 2019, Bangkok Post reported.
ANTARA reported that Indonesia's Environment Ministry was still preparing the implementing regulation for the Nagoya Protocol in 2025.
In court and with insurers
Lawsuits and rulings
Insurers
What we don't know
Nature
- Not measured Harm to nature: The record holds no measurement of harm to nature.
Record
- None on record Not stated in the sources reviewed: whether any benefit-sharing payment followed from the jamu or kratom patents.
- None on record Not stated in the sources reviewed: the outcome of the kratom patent objections after 2019.
Did the harm stop?
Not stated in the sources reviewed.
Who paid?
Not stated in the sources reviewed.
Sources
Press and investigations
Researchers
- Indonesian biopiracy article (manuscript 202506.1147)Preprints.org · 2025